All In Biotech

Drug Trial Radar · NCT01838551

Treatment for Endogenous Cushing's Syndrome

An Open Label Study to Assess the Safety and Efficacy of COR-003 (Levoketoconazole) in the Treatment of Endogenous Cushing's Syndrome

Last checked: Nov 20, 2026Latest source record: Apr 19, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

94

Actual

Start

Aug 2014

Primary completion

Apr 2018

Study completion Nov 2018

Sponsor

Lead sponsor
Cortendo ABIndustry
Sponsor type
Industry
First posted
Apr 24, 2013

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Non randomized
Model
Sequential
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary objectives of this study are to evaluate the clinical responder rate, defined as the proportion of subjects with normal UFC after 6 months of treatment with COR-003 in the Maintenance Phase without dose increase, and to evaluate the range of effective doses in subjects with various levels of hypercortisolism.

Conditions

  • Endogenous Cushing's Syndrome

Interventions

  • LevoketoconazoleDrug

    Levoketoconazole is the 2S,4R- enantiomer derived from racemic ketoconazole

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Normalization in Urinary Free Cortisol in Patients With Endogenous Cushing's Syndrome.Time frame: 6 months of maintenance phase therapy without a prior dose increase during that phase

Locations

42 sites in 15 countries. Site status is shown where the registry gives one.

  • UCLA School of Medicine

    Los Angeles, California

  • Johns Hopkins University

    Baltimore, Maryland

  • Massachusetts General Hospital

    Boston, Massachusetts

  • University of Michigan Medical Center

    Ann Arbor, Michigan

  • University of New Mexico HSC

    Albuquerque, New Mexico

  • Memorial Sloan Kettering Cancer Center

    New York, New York

  • Cleveland Clinic

    Cleveland, Ohio

  • Oregon Health & Science University

    Portland, Oregon

  • Allegheny Neuroendocrinology Center

    Pittsburgh, Pennsylvania

  • University Hospitals Leuven Department of Endocrinology

    Leuven, Belgium

  • University Specialized Hospital for Active Treatment in Endocrinology (USHATE)

    Sofia, Bulgaria

  • St. Pauls Hospital/Vancouver General Hospital

    Vancouver, British Columbia, Canada

  • Vseobecna fakultni nemocnice v Praze - III. Interni klinika VFN a 1. LF UK

    Prague, Czechia

  • Aarhus University Hospital

    Aarhus, Denmark

  • Rigshospitalet,Copenhagen University Hospital

    Copenhagen, Denmark

  • Hôpital de la CONCEPTION, Service d'Endocrinologie, Diabète et Maladies Métaboliques

    Marseille, France

  • Med Clinic I - University of Lueback

    Lübeck, Germany

  • Bnail Zion Medical Center Institute of Endocrinology & Metabolism

    Haifa, Israel

  • Institute of Endocrinology & Metabolism, Rabin Medical Center

    Petah Tikva, Israel

  • Sourasky Medical Center, Endocrinology & Metabolism

    Tel Aviv, Israel

  • Azienda Ospedaliera-Universitaria Ancona

    Ancona, Italy

  • UOC di Endocrinologia, Dipartimento di Medicina Clinica e Sperimentale

    Messina, Italy

  • Istituto Auxologico Italiano

    Milan, Italy

  • University of Naples Federico II

    Naples, Italy

  • SCDU Medicina Interna I Università di Torino Dipartimento di Scienze Cliniche e Biologiche

    Orbassano, Italy

  • University of Padua

    Padova, Italy

  • Institute of Medical Pathology

    Roma, Italy

  • Azienda Ospedaliero - Universitaria Città della Salute e della Scienza di Torino

    Torino, Italy

  • Policlinico GB Rossi

    Verona, Italy

  • Leiden University, Leiden University Medical Center, Dept. of Endocrinology

    Leiden, Netherlands

  • Erasmus MC, Dpt. Of Internal Medicine, Division of Endocrinology

    Rotterdam, Netherlands

  • Instytut Centrum Zdrowia Matki Polki

    Lodz, Poland

  • Terpa Sp.z.o.o

    Lublin, Poland

  • Szpital Kliniczny im. Heliodora Swiecickiego

    Poznan, Poland

  • Outpatient Clinic: Reuma Centrum

    Warsaw, Poland

  • Samodzielny Publiczny Szpital Kliniczny Nr 1

    Wroclaw, Poland

  • Clinical Center of Serbia

    Belgrade, Serbia

  • Endocrinologia, Hospital Sant Pau,Universitat Autònoma de Barcelona

    Barcelona, Spain

  • Hospital Universitario Reina Sofía

    Córdoba, Spain

  • Hospital Universidad De La Ribera

    Alzira, Valencia, Spain

Showing 40 of 42 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.